EyePoint Plc (EYPT)
13.37
+0.35
(+2.69%)
USD |
NASDAQ |
Apr 02, 11:54
EyePoint EPS Diluted (Quarterly) : -0.8143 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.29 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Cellectar Biosciences, Inc. | -1.249 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.61M |
| Revenue (Quarterly) | 0.62M |
| Total Expenses (Quarterly) | 68.23M |
| Enterprise Value | 802.99M |
| Gross Profit Margin (Quarterly) | -16.77% |
| Profit Margin (Quarterly) | -10.90K% |
| Earnings Yield | -23.66% |
| Normalized Earnings Yield | -23.66 |